The Asia Pacific Chronic Disease Management Market would witness market growth of 12.4% CAGR during the forecast period (2022-2028).
Programs for managing diseases aim to enhance the health of people with certain chronic conditions while lowering the demand for medical services and associated expenses for consequences that can be avoided, like hospital stays and ER visits. For many people involved in disease management programmes, there have been significant decreases in the usage of healthcare services and costs. But, disease management is still a young field, and regimens are constantly changing. The long-term effects of this strategy are therefore unknown.
Patients in these programmes must get continual education from doctors and other professionals on how to effectively manage their diseases. To maintain uniformity in treatment across the target audience, many programmes offer doctors practice guidelines that are based on clinical evidence. Managed health care plans have created and executed many disease management programmes. Nearly all health care plans have at least one disease management programme in place, and many have several.
Due to a rise in medical tourism, the adoption of innovative ICT guidelines in Japan, investments and reforms to update China's healthcare system, the rapid expansion of the healthcare sector in India, and the introduction of IT programmes in Australia and New Zealand, Asia-Pacific is expected to experience profitable growth. Additionally, government initiatives for the implementation of HCIT, an increase in the elderly population, an expansion in the number of chronic diseases, an increase in healthcare spending, and a rise in customer purchasing power are all predicted to promote market expansion in this region.
The China market dominated the Asia Pacific Chronic Disease Management Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $801.6 million by 2028.The Japan market is estimated to grow a CAGR of 11.8% during (2022 - 2028). Additionally, The India market would experience a CAGR of 13.1% during (2022 - 2028).
Based on Type, the market is segmented into Solutions and Services. Based on End User, the market is segmented into Healthcare Providers, Healthcare Payers and Others. Based on Disease Type, the market is segmented into Diabetes, Cardiovascular diseases, Asthma, Chronic obstructive pulmonary disorders, Cancer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Chronic Disease Management Market is Projected to reach USD 9.9 Billion by 2028, at a CAGR of 11.7%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Infosys Limited, ExlService Holdings, Inc., Health Catalyst, Inc., AllScripts Healthcare Solutions, Inc., Koninklijke Philips N.V., Cognizant Technology Solutions Corporation, Casenet, LLC, Cedar Gate Technologies, Clinical Excellence, Inc., and Altruista Health, Inc.
By Type
By End User
By Disease Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
